Dr. Ravi Vij, M.D.
Claim this profileWashington University School of Medicine
Expert in Multiple Myeloma
Studies Acute Myelogenous Leukemia
31 reported clinical trials
51 drugs studied
Area of expertise
1Multiple Myeloma
Global LeaderStage I
Stage II
Stage III
2Acute Myelogenous Leukemia
FLT3 negative
CEBPA positive
Stage II
Affiliated Hospitals
Clinical Trials Ravi Vij, M.D. is currently running
Dendritic Cells
for Graft-versus-Host Disease
Dendritic cells (DCs) serve as sentries for the immune system. DCs recognize foreign compounds (antigens) in the body, which they internalize and process. When DCs uptake foreign antigens, they migrate to secondary lymphoid organs, where the processed antigens are presented to T cells. Various DC subsets with unique cell lineages, surface protein markers, and tissue localization determinants have been identified. For example, Langerhans cells (LCs) and interstitial dendritic cells (intDCs) are DCs found in stratified epithelia, such as the skin. Though both are expressed in the skin, they differ with respect to their origin and surface protein content and can activate distinct types of immune responses. They may also have different specificities for the capture of antigens and presentation to circulating T cells. To date, it is unknown what role, if any, the different DC populations that reside or repopulate in the skin play in the development and progression of skin graft-versus-host disease (GVHD) following bone marrow transplant.
Recruiting1 award N/A3 criteria
64Cu-LLP2A Imaging
for Blood Cancers
This phase of the protocol (protocol part B), seeks to evaluate the new formulation in healthy normal volunteers to confirm the new formulation provides comparable human dosimetry to which was seen and published in protocol part A. Additionally, the new formulation will be studied utilizing an expanded patient population to include patients with confirmed diagnosis of multiple myeloma (MM), low-grade lymphoma, or MM and lymphoma patients who are status post bone marrow transplant (BMT) with negative imaging and suspected recurrence.
Recruiting1 award Phase < 14 criteria
More about Ravi Vij, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 31 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Ravi Vij, M.D. has experience with
- Dexamethasone
- Lenalidomide
- Fludarabine
- Cyclophosphamide
- Ixazomib
- Elotuzumab
Breakdown of trials Ravi Vij, M.D. has run
Multiple Myeloma
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ravi Vij, M.D. specialize in?
Ravi Vij, M.D. focuses on Multiple Myeloma and Acute Myelogenous Leukemia. In particular, much of their work with Multiple Myeloma has involved Stage I patients, or patients who are Stage II.
Is Ravi Vij, M.D. currently recruiting for clinical trials?
Yes, Ravi Vij, M.D. is currently recruiting for 7 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Ravi Vij, M.D. has studied deeply?
Yes, Ravi Vij, M.D. has studied treatments such as Dexamethasone, Lenalidomide, Fludarabine.
What is the best way to schedule an appointment with Ravi Vij, M.D.?
Apply for one of the trials that Ravi Vij, M.D. is conducting.
What is the office address of Ravi Vij, M.D.?
The office of Ravi Vij, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.